Evaxion Biotech A/S (EVAX) Revenue (2019 - 2026)
Evaxion Biotech A/S (EVAX) revenue from Dec 31, 2019 to Mar 31, 2026. The TTM Evaxion Biotech A/S (EVAX) revenue is $7.55M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Evaxion Biotech A/S (EVAX) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +121.41% |
Annual Revenue change of Evaxion Biotech A/S (EVAX)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $0 | -100.00% |
| 2025 | $7.53M | +125.45% |
| 2024 | $3.34M | +4671.43% |
| 2023 | $70K | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |